Analyst firms · William Blair · XRAY
William Blair XRAY price target and rating history
DENTSPLY SIRONA Inc. (XRAY) · Health Care
William Blair rates DENTSPLY SIRONA Inc. (XRAY) Mkt Perform, as of its latest action on Nov 7, 2025. It has published 5 rating actions on XRAY since April 2022, including 2 upgrades and 3 downgrades. Across 4 firms with a XRAY price target in the last 12 months, the median target is $12.
- Current rating
- Mkt Perform
- Price target
- Not stated
- Median target, all firms
- $12
- Actions on XRAY
- 5
Every William Blair rating on XRAY
- Nov 7, 2025
- Nov 10, 2023
- Jan 12, 2023
- Aug 5, 2022
- Apr 20, 2022
How other firms rate XRAY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Market Perform | $12 | Jul 9, 2026 |
| Citigroup | Sell | $10 | Apr 15, 2026 |
| BofA Securities | Buy | $17 | Feb 19, 2026 |
| Barclays | Underweight | $12 | Dec 9, 2025 |
Questions about William Blair and XRAY
- What is William Blair's rating on XRAY?
- William Blair rates XRAY Mkt Perform, a neutral rating, as of Nov 7, 2025.
- When did William Blair last change its view on XRAY?
- On Nov 7, 2025, William Blair downgrades to Mkt Perform from Outperform.
- How does William Blair's XRAY target compare with other analysts?
- Across 4 firms with a XRAY price target in the last 12 months, the median target is $12.
More XRAY rating histories
All William Blair ratingsXRAY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.